Blackstone Executive Vice Chairman Tony James says he's less optimistic now than before that the U.S.-China trade war could be resolved, but even a smaller deal could help...World Economyread more
The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
The stock of Allergan seems to be on a one-way path of struggle and endless competition, CNBC's Jim Cramer said on Thursday.
"It can't catch a break," the "Mad Money" host told a caller in the lightning round. "Sage Therapeutics has got a competitive drug to something that they may be doing for depression. The other day we saw another company, Revance [Therapeutics], have a competitive product to Botox. Doesn't matter that the CEO, Brent Saunders, just bought a lot of stock. Nothing matters. This stock is a one-way stock."
"It is the anti-bitcoin," Cramer said.
It's easy to call the market "crazy" or "irrational" in the face of an unexpected sell-off like the one that happened in the technology stocks this week, Cramer said on Thursday.
"But the market's not crazy, nor is it irrational," he said. "In reality, traders tend to make wild over-generalizations. They act fast, they paint with too broad a brush and it's a mistake to assume that they really know what they're doing. In short, the market's often wrong."
Even as tech stocks recovered later in the week, Cramer wanted to point out some of the most puzzling names that were thrown away by hasty sellers.
Cramer began with the stock of Salesforce.com, a massive cloud company with its hands in nearly every part of customer relations and enterprise software.
"After its recent ascent, bitcoin's become some sort of abstruse casino game that seems to have only winners and no losers. You've got to like that, right? I think, though, that could change," Cramer said. "Whenever any security runs from $5,000 to $10,000 to $15,000 to $19,000 in a matter of weeks or even hours, you've gotta wonder how long it will be before it bursts."
Given the buzz around bitcoin, Cramer said that it could still have room to run even after Thursday's rally, which brought the digital currency above $19,000 for the first time.
But the "Mad Money" host still came up with five reasons to be suspicious of the trend.
"I think tax reform is the single most important thing we can do in this country to unleash economic energy. It's going to unleash growth," Muilenburg told Cramer in an exclusive interview on Thursday.
Corporate tax cuts would be particularly good for Boeing, which had a 23 percent effective tax rate in 2016, according to the non-profit Institute on Taxation and Economic Policy.
Muilenburg said that the global aircraft manufacturer would put the additional cash to work mainly by boosting its $6-billion-a-year research and development budget.
Passenger traffic in the travel sector is growing at 7 percent a year — outpacing the United States' near-2 percent GDP growth — and Boeing is at the center of the trend, Muilenburg said on Thursday.
"The nature of the business has changed. Global traffic has become very networked, very connected," Muilenburg told Cramer. "We've got millions of new people traveling every year. And so our business has turned from being a cyclical, commercial business to a long-term sustained growth business."
As a company that focuses on long-term prospects (and one of the few public companies with a 20-year plan), Boeing is ramping up production to meet the pace of growth, the CEO said.
Muilenburg also talked up his company's partnership with NASA, saying that Boeing will beat Elon Musk's SpaceX in a space race to Mars.
Disclosure: Cramer's charitable trust owns shares of Allergan.